In this interview, David Eagle, MD, Chair of Legislative Affairs and Patient Advocacy, discusses the Centers for Medicare & Medicaid Services (CMS) policy that prohibits community oncology practices from mailing oral cancer therapies or allowing family members to pick them up.

Among American men, prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer-related death after lung cancer.

Prostate cancer can be detected early through PSA (prostate-specific antigen) testing and digital rectal exams, which can lead to further evaluation when abnormalities are found, according to Dr. David A. Taub.

Amy Frank said it took 17 hours on the phone over nearly three weeks, bouncing between her insurer and her local hospital system, to make sure her plan would cover her husband’s post-surgery care.

There is a deadly condition in the United States that has received almost no attention and is not being addressed. It is not a disease or sociodemographic characteristic. It is churn.

How should patients approach using AI-powered services? A new study provides insight into this question for the fast-moving field of blood cancer, evaluating the quality of responses by ChatGPT to a set of 10 medical questions.

Amid constant calls for reform among the prescription drug market’s middlemen, or pharmacy benefit managers (PBMs), many experts have begun to uncover practices that directly impact access to medications and patient outcomes.

A first-of-its-kind, federally funded clinical trial has shown it’s possible to identify breast cancer survivors who are at higher risk of their cancer coming back due to the presence of dormant cancer cells and to effectively treat these cells with repurposed, existing drugs.

Dr. Paul Gellhaus, urologic oncologist and medical director of robotic surgery at City of Hope Cancer Center Phoenix, emphasizes that fear often keeps patients from prostate cancer screening.

Changes in screening recommendations over a decade ago may have inadvertently resulted in later diagnosis of the most common cancer in men, a new study has found.